Cargando…
Effects of liraglutide on metabolic syndrome in WBN/Kob diabetic fatty rats supplemented with a high‐fat diet
BACKGROUND: Liraglutide, a GLP‐1 receptor agonist, has recently been used to treat metabolic syndrome (MS) because of its anti‐diabetic and anti‐obesity effects. We have previously shown that Wistar Bonn Kobori diabetic and fatty (WBN/Kob‐Lepr(fa), WBKDF) rats fed a high‐fat diet (HFD) developed MS...
Autores principales: | Kaji, Noriyuki, Takagi, Yoshiichi, Matsuda, Satomi, Takahashi, Anna, Fujio, Sakurako, Asai, Fumitoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167233/ https://www.ncbi.nlm.nih.gov/pubmed/32318661 http://dx.doi.org/10.1002/ame2.12106 |
Ejemplares similares
-
Characteristics of WBN/Kob diabetic fatty rats supplemented with a
fructose-rich diet as a metabolic syndrome model: response to a GLP-1 receptor
agonist
por: NAMEKAWA, Junichi, et al.
Publicado: (2018) -
Effects of high-fat diet and fructose-rich diet on obesity, dyslipidemia and
hyperglycemia in the WBN/Kob-Lepr(fa) rat, a new model of type 2
diabetes mellitus
por: NAMEKAWA, Junichi, et al.
Publicado: (2017) -
Effects of high‐sodium intake on systemic blood pressure and vascular responses in spontaneously diabetic WBN/Kob‐Lepr
(fa/fa) rats
por: Takagi, Yoshiichi, et al.
Publicado: (2017) -
High-Salt Intake Ameliorates Hyperglycemia and Insulin Resistance in WBN/Kob-Lepr(fa/fa) Rats: A New Model of Type 2 Diabetes Mellitus
por: Takagi, Yoshiichi, et al.
Publicado: (2018) -
Role of Insulin Resistance in the Pathogenesis and Development of Type 2
Diabetes in WBN/Kob-Lepr(fa)
Rats
por: OKUNO, Akira, et al.
Publicado: (2013)